LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
LBPH
Delisted
LBPH was delisted on the 29th of November, 2024.
18 hedge funds and large institutions have $23.3M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$857K | |
| 2 | +$534K | |
| 3 | +$15.4K | |
| 4 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$14K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.76K |
Top Sellers
| 1 | -$419K | |
| 2 | -$268K | |
| 3 | -$181K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$23K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.03K |